相关实验视频

Updated: Jun 26, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.2K

药物学静脉血栓塞栓症预防在患有非创伤性脑下垂体出血需要外腔室排水的患者

Chidozie Ukpabi1, Ofer Sadan2, Yuyang Shi3

  • 1Department of Clinical Pharmacy, Emory Healthcare, Atlanta, GA, USA. Chidozie.ukpabi@emoryhealthcare.org.

Neurocritical care
|May 10, 2024
PubMed
概括

在带有外部心室排水的脑下下垂层出血患者中预防血栓的最佳剂量尚不清楚. 这项研究发现,埃诺沙巴林,肝素或没有预防的VTE或ICH率之间没有显著差异.

关键词:
动脉瘤/副arachnoid 动脉瘤出血这是一种抗凝血药物.大脑脊髓液排水的排水.凝血是凝固的过程.深静脉血栓形成的原因之一是深静脉血栓.埃诺克萨帕林是一种素.头部液体 (Hydrocephalus) 是一种脑水性疾病.内压力 内压力室内静脉出血 室内静脉出血神经临界护理是指神经临界护理.神经外科 神经外科药理学 药理学是指药理学的学科.静脉血栓塞栓症是一种静脉血栓塞栓症.

更多相关视频

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation09:01

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

7.6K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

618

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K